Massachusetts · 17281

Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Massachusetts

Massachusetts Medicare Avg
$128.77
14% above national avg
National Medicare Avg
$112.86
All states combined
Billed Charge (MA)
$509.50
What providers submit
Est. Commercial (MA)
$441.27
National avg: $335.02
Est. Cash / Self-Pay (MA)
$267.40
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

826
Services in MA
154
Providers
N/A
Min Payment
N/A
Max Payment

Massachusetts Pricing in Context

In Massachusetts, CPT code 17281 (Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm) carries an average Medicare payment of $128.77 — 14% above the national benchmark of $112.86. 154 providers across the state submitted claims for this procedure in 2023, performing 826 total services. Individual payments in MA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Massachusetts is $509.50, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Massachusetts sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Massachusetts lands near $441.27, with self-pay cash prices typically around $267.40. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cost in Massachusetts?

The average Medicare payment for Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Massachusetts is $128.77, which is 14% above the national average of $112.86. Providers in MA typically bill $509.50 for this procedure.

What does Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cost with insurance in Massachusetts?

With commercial insurance in Massachusetts, Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm costs an estimated $441.27. Without insurance, the estimated cash price is $267.40. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Massachusetts?

154 providers in Massachusetts billed Medicare for Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in 2023, performing 826 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cheaper in Massachusetts than the national average?

No — Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm costs 14% above the national average in Massachusetts. The state average Medicare payment is $128.77 compared to $112.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial